Evidence map›Paper›PMID 39063229›Full record

SynthesisInternational journal of molecular sciences2024

Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.

Md Sadman Sakib Saadi, Rajib Das, Adhithya Mullath Ullas, Diane E Powell, Emma Wilson, Ioanna Myrtziou, Chadi Rakieh, Ioannis Kanakis

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Heart Failure and Osteoporosis: Shared Challenges in the Aging Population.Journal of cardiovascular development and disease · 2025
    Review
  10. Metformin and bone metabolism: unraveling their direct and indirect effects.Therapeutic advances in endocrinology and metabolism · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Md Sadman Sakib SaadiChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.
Rajib DasChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.
Adhithya Mullath UllasChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.ORCID 0009-0006-6873-327X
Diane E PowellMetabolic Bone Service, Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry SY10 7AG, UK.
Emma WilsonChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.ORCID 0000-0001-5064-2966
Ioanna MyrtziouChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.ORCID 0000-0003-1974-1194
Chadi RakiehMetabolic Bone Service, Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry SY10 7AG, UK.
Ioannis KanakisChester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.ORCID 0000-0001-6410-1482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic bone disease (DBD) is a frequent complication in patients with type 2 diabetes mellitus (T2DM), characterised by altered bone mineral density (BMD) and bone turnover marker (BTMs) levels. The impact of different anti-diabetic medications on the skeleton remains unclear, and studies have reported conflicting results; thus, the need for a comprehensive systematic review is of paramount importance. A systematic search was conducted in PubMed and the Cochrane Library. The primary outcomes assessed were changes in BMD in relation to different anatomical sites and BTMs, including mainly P1NP and CTX as well as OPG, OCN, B-ALP and RANK-L. Risk of bias was evaluated using the JADAD score. The meta-analysis of 19 randomised controlled trials comprising 4914 patients showed that anti-diabetic medications overall increased BMD at the lumbar spine (SMD: 0.93, 95% CI [0.13, 1.73],

Indexed as

BiomarkersBone DensityBone RemodelingDiabetes Mellitus, Type 2Hypoglycemic AgentsHumansMetforminBiomarkersHypoglycemic AgentsMetforminanti-hyperglycaemic drugsbone mineral densitybone turnover markersdiabetic bone diseasefracture risktype 2 diabetes mellitus

Identifiers

PMID39063229
PMCPMC11277066

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.